Abstract
This study investigated the mechanism of carbapenem resistance in an Enterobacter cloacae complex positive by the modified carbapenem inactivation method (mCIM) but negative by the Rosco Neo-Rapid Carb Kit, β CARBA, and conventional PCR for common carbapenemase genes (KPC, NDM, OXA-48, IMP, VIM, GES, and IMI/NMC). Using whole genome sequencing (WGS) data we confirmed the identification of Enterobacter asburiae (ST1639) and the presence of blaFRI-8 located on a 148kb IncFII(Yp) plasmid. This is the first occurrence of a clinical isolate harboring the FRI-8 carbapenemase and the second occurrence of FRI in Canada. This study highlights the need to use both WGS and phenotypic screening methods for detection of carbapenemase-producing strains if we consider the growing diversity of carbapenemases.
Author supplied keywords
Cite
CITATION STYLE
Mataseje, L. F., Doualla-Bell, F., Boyd, D. A., Fakharuddin, K., Felipe Garcia Jeldes, H., Plante, V., … Mulvey, M. R. (2023). Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8. Microbial Drug Resistance, 29(2), 47–50. https://doi.org/10.1089/mdr.2022.0123
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.